Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Executive Selling Activity and Analyst Revisions at Globe Life Inc.

Executive Selling Activity and Analyst Revisions at Globe Life Inc.

The Chief Financial Officer of Globe Life Inc., Thomas Peter Kalmbach, recently sold a significant block of company shares. This activity was reported against a backdrop of mixed financial news for the quarter, where revenue met expectations but earnings per share fell slightly short. Despite this initial miss, major investment banks have subsequen…

Executive Activity at TFS Financial Highlights Recent Stock Sales and Corporate Governance Shifts

Executive Activity at TFS Financial Highlights Recent Stock Sales and Corporate Governance Shifts

Cathy W. Zbanek, Chief Synergy Officer at TFS Financial CORP (NASDAQ:TFSL), executed a recent sale of common stock shares totaling $152,600. The report details her current holdings, including direct shares, indirect company plan allocations like 401(k) and ESOP units, and various derivative rights. Furthermore, the article outlines significant corp…

Ampco Pittsburgh CEO Purchases Shares Amid Market Volatility

Ampco Pittsburgh CEO Purchases Shares Amid Market Volatility

The Chief Executive Officer of Ampco Pittsburgh Corp., Brett McBrayer, recently acquired a significant block of the company's common stock. This personal transaction occurred following a period of notable stock decline for the firm. Separately, Ampco-Pittsburgh disclosed its first quarter 2026 financial results, reporting a net loss and an earnings…

Insider Buying Activity at Orchestra BioMed Highlights Internal Confidence Amid Mixed Analyst Signals

Insider Buying Activity at Orchestra BioMed Highlights Internal Confidence Amid Mixed Analyst Signals

A recent regulatory filing disclosed that director Aryeh Jason increased his personal stake in Orchestra BioMed Holdings, Inc. (OBIO) through the purchase of common stock. This insider activity occurs while the company's valuation is subject to adjustments from major financial institutions, coupled with ongoing clinical data presentations regarding…

Artiva Biotherapeutics' Insider Activity and Clinical Progress Provide Mixed Signals for Investors

Artiva Biotherapeutics' Insider Activity and Clinical Progress Provide Mixed Signals for Investors

Senior Vice President Heather Raymon executed automatic stock sales totaling $27,879 on May 19, 2026, under a 'sell-to-cover' policy related to restricted stock units. Despite this insider selling and recent stock decline of 18.6% over the past week, Artiva Biotherapeutics (NASDAQ:ARTV) has seen significant clinical advancements, including promisin…

Artiva Biotherapeutics Officer Sells Shares Amid Stock Volatility; Company Advances Clinical Data and Leadership

Artiva Biotherapeutics Officer Sells Shares Amid Stock Volatility; Company Advances Clinical Data and Leadership

Christopher Horan, Chief Tech Operations Officer at Artiva Biotherapeutics, Inc., recently sold a portion of his common stock. This transaction was part of the company’s automatic 'sell-to-cover' policy to satisfy tax withholding requirements related to vested restricted units. While the sale occurred amidst short-term volatility for the stock, Art…